The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy

被引：0
|
作者：
Qiying Zhang
Zi Liu
Yali Wang
Jing Zhang
Wen Li
Tao Wang
Juan Wang
Fan Shi
Jin Su
机构：
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Radiation Oncology
[2] The Second Affiliated Hospital of Xi’an Jiao Tong University,Department of Radiation Oncology
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
Cervical cancer; Minimally invasive surgery; Open surgery; Radiotherapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer
    Takeshima, Nobuhiro
    Umayahara, Kenji
    Fujiwara, Kiyoshi
    Hirai, Yasuo
    Takizawa, Ken
    Hasumi, Katsuhiko
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 618 - 622
  • [22] Postoperative adjuvant therapy in early invasive cervical cancer patients with histopathologic high-risk factors
    Park, TK
    Kim, SN
    Kwon, JY
    Mo, HJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (06) : 475 - 482
  • [23] Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary Thyroid Cancer
    Zhou, Huijun
    Wu, Jie
    Shi, Lei
    Wang, Yu
    Liu, Bin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : 3389 - 3397
  • [24] Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
    J V Hegde
    D J Margolis
    P-C Wang
    R E Reiter
    J Huang
    M L Steinberg
    M Kamrava
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 241 - 248
  • [25] Clinical outcomes of whole pelvis radiotherapy and stereotactic body radiotherapy boost for intermediate- and high-risk prostate cancer
    Kim, Hun Jung
    Phak, Jeong Hoon
    Kim, Woo Chul
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E342 - E347
  • [26] Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
    Kubo, Nobuteru
    Kawamura, Hidemasa
    Oike, Takahiro
    Sato, Hiro
    Iwanaga, Mototaro
    Mizukami, Tatsuji
    Adachi, Akiko
    Matsui, Hiroshi
    Ito, Kazuto
    Suzuki, Kazuhiro
    Nakano, Takashi
    IN VIVO, 2019, 33 (04): : 1235 - 1241
  • [27] Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Zumsteg, Zachary S.
    Zelefsky, Michael J.
    Woo, Kaitlin M.
    Spratt, Daniel E.
    Kollmeier, Marisa A.
    McBride, Sean
    Pei, Xin
    Sandler, Howard M.
    Zhang, Zhigang
    BJU INTERNATIONAL, 2017, 120 (5B) : E87 - E95
  • [28] Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
    Agusti, Nuria
    Viveros-Carreno, David
    Wu, Chi-Fang
    Wilke, Roni Nitecki
    Kanbergs, Alexa
    Barajas, Karla
    Zamorano, Abigail S.
    Pareja, Rene
    Melamed, Alexander
    Rauh-Hain, J. Alejandro
    JAMA ONCOLOGY, 2025,
  • [29] TREATMENT RESULTS OF PDR BRACHYTHERAPY COMBINED WITH EXTERNAL BEAM RADIOTHERAPY IN 106 PATIENTS WITH INTERMEDIATE- TO HIGH-RISK PROSTATE CANCER
    Pieters, Bradley R.
    Geijsen, Elisabeth D.
    Koedooder, Kees
    Blank, Leo E. C. M.
    Rezaie, Elisa
    van der Grient, Johan N. B.
    de Reijke, Theo M.
    Koning, Caro C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1037 - 1042
  • [30] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Ali S. Alzahrani
    Noha Mukhtar
    Endocrine, 2022, 78 : 531 - 542
12345